• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Aug14
Pharmesis released FY2025 Q2 earnings on August 14, Post-Market (SGT), actual revenue SGD 2.421 M, actual EPS SGD -0.0038
15:00
Pharmesis released FY2025 Q1 earnings on August 14, 2025 (SGT) with actual revenue of SGD 2.512 M and EPS of SGD -0.0039
15:00
Pharmesis released FY2025 Semi-Annual earnings on August 14, 2025 (SGT) with actual revenue of SGD 4.933 M and EPS of SGD -0.0078
15:00
Feb28
Pharmesis released FY2024 Q3 earnings on February 28, 2025 (SGT) with actual revenue of 3.997 M SGD and EPS of 0.0338 SGD
15:00
Pharmesis released FY2024 9 Months Earnings on February 28 (SGT), with actual revenue of 8.454 M SGD and EPS of 0.0106 SGD
15:00
Pharmesis released FY2024 Annual Earnings on February 28 (SGT) with actual revenue of 12.56 M SGD and actual EPS of 0.0514 SGD
15:00

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(CST)

FY2025 Q2 Earning Release (SGD) Revenue 2.421 M, Net Income -122.09 K, EPS -0.0038

Feb28
Earning Release(CST)

FY2024 Q4 Earning Release (SGD) Revenue 4.08 M, Net Income 1.096 M, EPS 0.0345

Aug12
Earning Release(CST)

FY2024 Q2 Earning Release (SGD) Revenue 2.227 M, Net Income -324.83 K, EPS -0.0115

View More

Stock List

Top Gainers
Top Decliners
Popular
Symbol
Price
%Chg
Change
532
0.002
+100.00%
+0.001
UVYW
0.009
+50.00%
+0.003
SCEW
0.080
+37.93%
+0.022
504
0.004
+33.33%
+0.001
VY2W
0.056
+30.23%
+0.013
RXMW
0.018
+28.57%
+0.004
596
0.039
+25.81%
+0.008
SEJ
0.069
+23.21%
+0.013
F10
0.011
+22.22%
+0.002
FTAW
0.055
+17.02%
+0.008
View More